RHHVF

Roche Holding Ltd

 
Rights - Dividend Rights Certificates International Reporting
OTCQX International Premier OTCQX Advisor: J.P. Morgan
Verified Company Profile 2/21/2017
Contact Info
  • Grenzacherstrasse 124
  • Basel 4070
  • Switzerland

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: SIX Swiss Exchange
Audited Financials Audited
Latest Report Jun 30, 2017 Semi-Annual Report
CIK 0000896566
Fiscal Year End 12/31
OTC Marketplace OTCQX International Premier
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Switzerland
Year of Inc. 1896
Employees 91747 a/o Dec 31, 2015
Company Officers/Contacts
Severin Schwan CEO
Alan Hippe CFO
Sonya Schwab Administrator
Karl Mahler Head of IR
Company Directors
Christoph Franz Chairman
Pius Baschera
John Irving Bell
Julie Brown
Paul Bulcke
Claudia Sussmuth Dyckerhoff
Andre Hoffmann
Richard Lifton
Andreas Oeri
Bernard Poussot
Severin Schwan
Peter Voser
Company Notes
  • Sponsored for OTCQX by J.P. Morgan on 10/1/2015
Service Providers
OTCQX Advisor
J.P. Morgan
4 New York Plaza
14th Floor
New York, NY, 10004
USA

Accounting/Auditing Firm
KPMG AG
Ganghoferstrasse 29
Munich, 80339
Germany

Legal Counsel
Not Available
Investor Relations Firm
Not Available
RHHVF Security Details Other Company Securities
Share Structure
Market Value1 $176,554,006,510 a/o Aug 15, 2017
Authorized Shares 702,562,700 a/o Jan 11, 2017
Outstanding Shares 702,562,700 a/o Jan 11, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 702,400,592 a/o Jan 11, 2017
Par Value No Par Value
Transfer Agent(s)
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
ROG - SIX Swiss Exchange - Qualified
Short Selling Data
Short Interest 457,201 (-31.89%)
Jul 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security